Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Inc. Implements 1-for-4 Reverse Stock Split to Boost Share Price and Maintain Nasdaq Listing

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$5.66
Mkt Cap
$2.851M
52W Low
$4.62
52W High
$398.86
Market data snapshot near publication time

summarizeSummary

PMGC Holdings Inc. has completed a 1-for-4 reverse stock split, effective January 6, 2026, to increase its per-share price and maintain compliance with Nasdaq listing requirements.


check_boxKey Events

  • Reverse Stock Split Effective

    A 4-for-1 reverse stock split became effective on January 6, 2026, automatically combining every four shares of common stock into one.

  • Nasdaq Trading Adjustment

    The company's common stock began trading on a split-adjusted basis on the Nasdaq Capital Market under the existing ticker 'ELAB' with a new CUSIP number.

  • Authorized Shares Adjusted

    The total authorized capital stock was set at 1,000,000,000 shares, comprising 500,000,000 common shares and 500,000,000 preferred shares.

  • Equity Instrument Adjustments

    Outstanding stock awards, options, equity incentive plan reserves, and warrants (shares and exercise prices) were proportionally adjusted to reflect the split.


auto_awesomeAnalysis

The 1-for-4 reverse stock split by PMGC Holdings Inc. is a significant corporate action, typically undertaken by companies whose stock price has fallen to low levels, often below exchange minimums. While it does not change the fundamental value of the company, it reduces the number of outstanding shares and proportionally increases the share price, aiming to improve market perception and maintain listing eligibility on the Nasdaq Capital Market. Investors should monitor whether this action helps stabilize the stock price and if the company can demonstrate improved operational performance to sustain a higher valuation post-split.

At the time of this filing, ELAB was trading at $5.66 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $4.62 to $398.86. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ELAB - Latest Insights

ELAB
May 04, 2026, 5:14 PM EDT
Filing Type: PRE 14A
Importance Score:
8
ELAB
Apr 28, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
ELAB
Apr 27, 2026, 4:01 PM EDT
Filing Type: DEF 14C
Importance Score:
9
ELAB
Apr 24, 2026, 9:18 AM EDT
Filing Type: PRE 14C
Importance Score:
9
ELAB
Apr 23, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
ELAB
Apr 21, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
ELAB
Apr 20, 2026, 4:37 PM EDT
Filing Type: 424B5
Importance Score:
9
ELAB
Apr 17, 2026, 7:32 AM EDT
Filing Type: PRE 14C
Importance Score:
9
ELAB
Apr 17, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
9
ELAB
Apr 13, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7